1. Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences. (26th May 2018) Authors: Cacheux, Wulfran; Tsantoulis, Petros; Briaux, Adrien; Vacher, Sophie; Mariani, Pascale; Richard‐Molard, Marion; Buecher, Bruno; Richon, Sophie; Jeannot, Emmanuelle; Lazartigues, Julien; Rouleau, Etienne; Mariani, Odette; El Alam, Elsy; Cros, Jérôme; Roman‐Roman, Sergio; Mitry, Emmanuel; Girard, E... Journal: Cancer medicine Issue: Volume 7:Number 7(2018:Jul.) Page Start: 3213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). Issue 11 (14th October 2010) Authors: Dahan, Laetitia; Bonnetain, Frank; Ychou, Marc; Mitry, Emmanuel; Gasmi, Mohamed; Raoul, Jean-Luc; Cattan, Stéphane; Phelip, Jean-Marc; Hammel, Pascal; Chauffert, Bruno; Michel, Pierre; Legoux, Jean-Louis; Rougier, Philippe; Bedenne, Laurent; Seitz, Jean-François Journal: Gut Issue: Volume 59:Issue 11(2010) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Issue 10 (23rd August 2010) Authors: Mitry, Emmanuel; Guiu, Boris; Cosconea, Simona; Jooste, Valérie; Faivre, Jean; Bouvier, Anne-Marie Journal: Gut Issue: Volume 59:Issue 10(2010) Page Start: 1383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. Issue 7 (July 2022) Authors: Randrian, Violaine; Pernot, Simon; Le Malicot, Karine; Catena, Vittorio; Baumgaertner, Isabelle; Tacher, Vania; Forestier, Julien; Hautefeuille, Vincent; Tabouret-Viaud, Claire; Gagnaire, Alice; Mitry, Emmanuel; Guiu, Boris; Aparicio, Thomas; Smith, Denis; Dhomps, Anthony; Tasu, Jean-Pierre; Perd... Journal: Digestive and liver disease Issue: Volume 54:Issue 7(2022) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer. (July 2018) Authors: Zawadi, Mohamed-Ayman; Volet, Julien; Cavaglione, Gérard; Lepere, Céline; Rougier, Philippe; Zaanan, Aziz; Besson, Dominique; Fawzi, Kara Slimane; Adenis, Antoine; Gatineau-Sailliant, Gilles; Brezault, Catherine; Coriat, Romain; Tougeron, David; Hautefeuille, Vincent; Chone, Laurence; Molin, Yann... Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients. (March 2017) Authors: Aparicio, Thomas; Gargot, Dany; Teillet, Laurent; Maillard, Emilie; Genet, Dominique; Cretin, Jacques; Locher, Christophe; Bouché, Olivier; Breysacher, Gilles; Seitz, Jean-François; Gasmi, Mohamed; Stefani, Laetitia; Ramdani, Mohamed; Lecomte, Thierry; Auby, Dominique; Faroux, Roger; Bachet, Jean... Journal: European journal of cancer Issue: Volume 74(2017) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer. (December 2019) Authors: Pérol, Maurice; Pavlakis, Nick; Levchenko, Evgeny; Platania, Marco; Oliveira, Julio; Novello, Silvia; Chiari, Rita; Moran, Teresa; Mitry, Emmanuel; Nüesch, Eveline; Liu, Ting; Balas, Bogdana; Konopa, Krzysztof; Peters, Solange Journal: Lung cancer Issue: Volume 138(2019) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer. (January 2020) Authors: Ou, Sai-Hong Ignatius; Gadgeel, Shirish M.; Barlesi, Fabrice; Yang, James Chih-Hsin; De Petris, Luigi; Kim, Dong-Wan; Govindan, Ramaswamy; Dingemans, Anne-Marie; Crino, Lucio; Léna, Hervé; Popat, Sanjay; Ahn, Jin Seok; Dansin, Eric; Mitry, Emmanuel; Müller, Barbara; Bordogna, Walter; Balas, Bogda... Journal: Lung cancer Issue: Volume 139(2020) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Issue 6 (June 2015) Authors: Gauthé, Mathieu; Richard-Molard, Marion; Cacheux, Wulfran; Michel, Pierre; Jouve, Jean-Louis; Mitry, Emmanuel; Alberini, Jean-Louis; Lièvre, Astrid; on behalf of the Fédération Francophone de Cancérologie Digestive (FFCD) Journal: Digestive and liver disease Issue: Volume 47:Issue 6(2015) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗